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Background: Enteric red mouth disease and Saprolegniasis, which are caused by the bacteria Yersinia ruckeri and
the oomycete Saprolegnia parasitica, respectively, are important illnesses that affect salmonid farming. Sanitary
problems in farms are addressed by the prevention of disease outbreaks or by the treatment of diseases with
chemicals. Environmental and governmental restrictions, toxicity and high treatment costs limit the use of
drugs. Marine organisms, such as algae, sponges and corals, have developed an antimicrobial defense strategy
based on the production of bioactive metabolites. Among these organisms, seaweeds offer a particularly rich
source of potential new drugs. Hence, many pharmacologically active substances have been isolated from
seaweeds. In the Ceramium genus, Ceramium rubrum has been emphasized by several authors for its antimicrobial
properties. Based on this background, the present study focused on the antimicrobial activity of a lipophilic extract
of C. rubrum on Y. ruckeri and S. parasitica.
Results: The alga, collected from the Paciﬁc coast of Chile, underwent an ethanol extraction, and the concentrated
extract was partitioned between water and dichloromethane. From the dichloromethane extract, fatty acids,
fatty acid esters, one hydrocarbon and phytol were identiﬁed by Gas Chromatography–Mass Spectrometry
(GC/MS) analysis. The antimicrobial study showed that the whole extract was more active than the individual
components, which suggests a strong synergistic effect among the components.
Conclusions: These results may constitute a basis for promising future applied research that could investigate the
use of C. rubrum seaweed as a source of antimicrobial compounds against ﬁsh pathogens.© 2014 Pontiﬁcia Universidad Católica de Valparaíso. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Enteric red mouth (ERM) disease and Saprolegniasis, which are
caused by the Gram-negative bacteria Yersinia ruckeri [1] and the
oomycete Saprolegnia parasitica [2], respectively, are important
illnesses that affect salmonid species and some ﬁsh wildlife. ERM
disease is controlled with antibiotics, such as quinolones, tiamulines,
sulfonamides, oxytetracycline and erythromycin, and antiseptics,).
d Católica de Valparaíso.
araíso. Production and hosting by Elsuch as iodophors [3]. Nevertheless, a decrease in drug efﬁcacy and
the development of bacterial resistance have limited their use [4]. A
previous study showed that Saprolegnia infection could be easily
controlled by the application of malachite green, a dye that can be
applied alone or in combination with other fungicides [5]. However,
since 2002, the use of malachite green has been banned worldwide
due to both carcinogenic and toxicological effects, which has allowed
Saprolegnia to become a major economic problem in freshwater ﬁsh
farms [6]. Alternative treatments include bronopol (30-100 mg l-1),
sodium chloride (30 g l-1), formalin (250 mg l-1), potassium
permanganate (10 mg l-1) and hydrogen peroxide [7]. However, none
of these chemicals aremore effective thanmalachite green. In summary,
sanitary problems, environmental and governmental restrictions,
solubility, toxicity and high cost have limited the use of synthetic
antimicrobials [8]; hence, research on new alternatives is necessary.sevier B.V. All rights reserved.
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of seaweeds have been reported to exhibit antibacterial activity [9,10,
11,12,13] and antifungal activity [10,14,15,16,17]. However, scarce
literature is available on the antibacterial and antifungal effects of extracts
from Ceramium rubrum (Hudson) (Rhodophyta: Florideophyceae).
C. rubrum is a marine alga that is found in both hemispheres on tropical
and polar coasts [18]. Hellio et al. [19] observed that the dichloromethane
extract of C. rubrum that was collected from the French coast elicited
antibacterial activity against several marine Gram-positive bacteria.
Similar results were reported by Bansemir et al. [11] with samples
collected from the German coast. Tuney et al. [20] observed that
diethyl ether and ethanol extracts also showed antibacterial properties.
Extracts obtained from theGerman samples usinghexane andmethanol
inhibited the growth of a variety of marine and ﬁsh bacteria [21].
Salvador et al. [22] evaluated the antibacterial effect of fresh and
lyophilized extracts and found that C. rubrum that was collected
from the Mediterranean and Atlantic coasts of Spain was active
against Gram-positive andGram-negative bacteria. There are no reports
regarding the antifungal activity of C. rubrum.
Seaweeds represent a great source of a variety of natural products
[23], but their veterinary potential in ﬁshes has barely been explored.
Therefore, the aim of this study was to investigate the antimicrobial
activity of the ethanol and dichloromethane extracts of C. rubrum
against Y. ruckeri and S. parasitica, two of the main microbial diseases
in Chilean farmed salmonids. The results obtained will form the basis
for further studies on marine natural products.
2. Materials and methods
2.1. Plant collection
The alga C. rubrum was collected in the summer of 2010 at the
mouth of the Maullín River, which is located to the northwest of the
town Maullín (Chile, Los Lagos Region). The collected material was
separated and washed with distilled water to remove traces of sand,
seaweed and other marine organisms. Finally, the material was kept
in plastic bags and frozen at -20°C.
2.2. Preparation of the extracts
The alga (20 kg) was extracted using 96% ethanol 3 times (each
extraction period was 24 h). After ﬁltration, the three extracted
solutions were pooled, and the solvent was evaporated in a rotary
evaporator,whichproduced the ethanol (E) extract. Thedichloromethane
(DCM) extract was obtained by the liquid–liquid separation of 250 g
of the E extract that was suspended in 1000 ml of distilled water
and subsequently extracted with three portions of dichloromethane
(500 ml). The resulting portions were combined to yielding DCM.
2.3. Gas Chromatography–Mass Spectrometry (GC/MS) analysis
The GC/MS analysis of the DCM was performed through electron
impact ionization (70 eV) using a Thermo Finnigan chromatograph
(Milan, Italy) that was equipped with a BP-1 capillary column (30 m
0.22 mm by 0.25 μm; SGE, Victoria, Australia) and used helium as the
carrier gas. The GC oven was programmed to ramp from 40 to
300°C at 5°C min-1 and held for 5 min. The injector and transfer line
temperatures were ﬁxed at 250°C. The column outlet was inserted
directly into the electron ionization source block. The scan range was
40–500 Da. Kovats indices (KIs) of the DCM compounds were
estimated by employing a series of homologous reference compounds.
The retention indices were determined relative to an n-alkane series
by means of linear interpolation. Compounds were identiﬁed through
a comparison between the KI and the mass spectra with available
commercial standards. For non-available standards, spectra were
compared with the library mass spectral NIST.3. Antimicrobial tests
3.1. Agar diffusion test
Bacterial inhibition was performed using the agar diffusion method
[24]. A Y. ruckeri pure strain culture was grown on Tryptic Soy Agar
(TSA) plates and incubated for 24 h at 26 ± 1°C. Then, a Tryptic Soy
Broth (TSB) suspension was prepared from 5 isolated colonies. The
culture tube was incubated for 2 h at 26 ± 1°C [1], until reaching
the turbidity equivalent to 0.5 McFarland standard (1.5 × 108 CFU ml-1).
Subsequently, TSA plates were inoculated with the bacterial suspension.
Sterilized paper disks (6 mm, Whatman No. 1) were impregnated with
2 μl of a 500 mg ml-1 (1 mg disk-1) solution of the E, the DCM and
the DCM compounds. Finally, the disks were deposited on Petri dishes
after solvent evaporation. Additionally, 0.02% of Tween 80 was gently
mixed into the agar after autoclaving the medium at 45°C to enhance
the solubility of the DCM and DCM compounds [25]. All antibiograms
were carried out in triplicate. Oxytetracycline disks (30 μg) were used
as positive control, and solvents and clean disks (without solvent) were
used as control tests. The plates were incubated for 24 h at 26 ± 1°C
[1], and the inhibition zones were measured taking into consideration
the paper disk diameter.
3.2. Agar dilution test
The E, DCM and DCM compounds obtained from C. rubrumwere
tested against S. parasitica using the agar dilution method. Stock
solutions (25,000 μg ml-1) were prepared, and 200 μl of each solution
and 19.8 ml of melted Sabouraud agar medium (SA) were pooled into
10 cm plates to achieve the desired concentration (250 μg ml-1). Ten
microliters of malachite green solution (500 μg ml-1) and 19.99 ml of
melted SA were pooled into positive control plates to achieve the
desired concentration (0.25 μg ml-1) [26]. Using the same method,
we prepared control plates that contained SA alone or SA plus 200 μl
of the solvent that was used in the stock solutions. Agar disks
(6 mm diameter and 3 mm thick) taken from the margins of actively
growing colonies of S. parasitica cultures were placed in the middle
of the plates. The experiments were carried out in triplicate. All of
the plates were incubated at 18 ± 1°C for 5 d in darkness. The fungal
growth was measured in cm from the agar disk margin [27], and the
inhibition of S. parasitica was obtained by comparing the fungal
colony growth diameter with the controls (only SA) [28].
3.3. Broth dilution test
Minimal inhibitory concentration (MIC) values for Y. ruckeri
and S. parasitica were determined by the broth dilution method.
In the antibacterial assays, a two-fold serial dilution of DCM was
prepared. Then, 800 μl of TSB, 100 μl of inocula compatible with 0.5
McFarland standard and 100 μl of each DCM dilution were added to
an assay tube to achieve concentrations between 1 and 2048 μg ml-1.
Oxytetracycline (0.5–1 μg ml-1) was used as the positive control.
All of the mixtures were made in triplicate and incubated for 24 h at
26 ± 1°C. Once the incubation time elapsed, the absorbance at 600 nm
was monitored [29]. The bacterial inhibition was calculated according to
the following equation: % growth inhibition = 100 - [absorbance of the
treatment tube / (absorbance of the growth control tube - the medium
control tube)] × 100 [30]. To determine the minimum bactericidal
concentration (MBC), a loopful of each assay tube that showed growth
inhibition was transferred into a Petri dish that only contained TSA [31].
For the antifungal assays, Saprolegnia agar pieces excised from
colonized SA plates were incubated in 500 ml of Sabouraud broth
(SB) at 21 ± 1°C for 2 d. Subsequently, the grown mycelia mass
was washed twice with sterile distilled water, transferred to an
Erlenmeyer ﬂask that contained 500 ml of sterile tap water and
incubated at 21 ± 1°C for 24 h. The spore suspensions were ﬁltered
Table 2
Antimicrobial activity of the investigated extracts and the DCM compounds against
Y. ruckeri and S. parasitica.
Extract/compound Y. ruckeri1
(mm of inhibition)
S. parasitica2
(% of inhibition)
TSA TSA + Tween 80 SA
E extract 8.7 ± 0.6b⁎ 8.1 ± 0.2c 1.7 ± 0.2f
DCM extract – 14.7 ± 0.6b 17.6 ± 0.2b
Ethyl myristate nt 7.3 ± 0.6d 1.7 ± 0.0f
Ethyl palmitate nt 8.0 ± 0.0c 10.8 ± 0.1c
Myristic acid nt 8.0 ± 0.0c 2.9 ± 0.2e
Palmitic acid nt 8.0 ± 0.0c 2.5 ± 0.2e
Oleic acid nt 7.2 ± 0.3d 1.0 ± 0.1g
Stearic acid nt 7.0 ± 0.0d 17.9 ± 0.1b
Phytol nt 8.0 ± 0.0c 5.0 ± 0.0d
a a
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counted using a Neubauer chamber. The cyst suspension was adjusted
to 5 × 105 spores ml-1 and transferred to the challenge tubes within
3 h of counting [33]. To determine the MIC value, a two-fold serial
dilution of DCM was prepared, and 800 μl of SB, 100 μl of inocula
and 100 μl of each dilution of DCM were added to an assay tube to
achieve the desired concentrations between 250 and 2000 μg ml-1.
Malachite green (0.1–0.5 μg ml-1) was used as the positive control
[26]. All of the mixtures were made in triplicate and incubated
for 5 d at 15 ± 1°C [34]. When the incubation time elapsed, the
absorbance at 550 nm was monitored [35]. The fungicidal inhibition
was calculated according to Leippe et al. [30], and theminimum fungicidal
concentration (MFC) was calculated according to Sreenivasan et al.
[31].Oxytetracycline (30 μg) 28.3 ± 0.6 27.9 ± 0.5 nt
Malachite green (0.25 μg ml-1) nt nt 44.2 ± 0.1a
1 Concentration tested: 1 mg disk-1; 2 250 μg ml-1 per plate. (–) not active. (nt) not tested.
⁎ The means that are followed by the same letter do not differ signiﬁcantly at p b 0.05
(Conover–Inman test).4. Results
4.1. GC/MS analysis
Twenty kilograms of C. rubrum yielded 250 g of the E extract.
Subsequently, the E was partitioned to obtain 75 g of the DCM. GC/MS
analysis of the DCM resulted in the identiﬁcation of 14 compounds
(one alkane, one ketone, fatty acids, fatty acid esters and one
diterpene). Phytol (44.7%) and palmitic acid (25.8%) were the
major components (Table 1). Seven of the compounds, representing
86.4% of the DCM, were tested in the antimicrobial assays.4.2. Antimicrobial activity
The E, the DCM and the compounds identiﬁed in the DCM inhibited
the growth of Y. ruckeri and S. parasitica, but all of these were less active
than thepositive controls (p b 0.04). The highest antibacterial inhibition
was achieved with the DCM (14.7mm), whereas the highest antifungal
inhibition was achieved with the DCM and with stearic acid (N17.6%).
None of the DCM compounds inhibited bacterial growth more
than the DCM; however, the DCM and stearic acid had similar
antifungal inhibition (Table 2). The MIC values of the DCM resulted
in 507.7 μg ml-1 and N2048 μg ml-1 for Y. ruckeri and S. parasitica,
respectively.
Four DCM compound mixtures were tested: reconstituted sample,
the main compounds, fatty acids and fatty acid esters. None of these
mixtures were more active than the DCM. There is a direct relation
between the antibacterial activity and the percentage of the compounds
of the DCM tested, which suggests that the minor compounds could
play an important role in the synergistic effect. In the antifungal assay,
the highest activities were achieved when the mixture tested included
stearic acid (Table 3).Table 1
Compounds identiﬁed by GC/MS analysis in the DCM obtained from C. rubrum.
Compound Rt1 Molecular ion Mean % ± SD2 KI (exp)3
Hexadecane 26.44 226 4.8 ± 1.9 1694
Myristic acid 27.72 228 4.1 ± 0.5 1756
Ethyl myristate 28.09 256 1.2 ± 0.5 1763
Hexahydrofarnesyl acetone 29.13 268 0.6 ± 0.1 1823
Hexadecenoic acid, Z-11 31.28 254 4.5 ± 1.3 1932
Palmitic acid 31.96 256 25.8 ± 4.9 1967
Ethyl palmitate 32.06 284 6.7 ± 3.2 1972
Phytol 34.38 296 43.2 ± 1.5 2097
Oleic acid 34.77 282 2.5 ± 0.7 2120
Stearic acid 35.19 284 1.3 ± 0.3 2144
Ethyl linoleate 37.07 308 0.6 ± 0.4 2150
Ethyl linolenate 37.14 306 0.1 ± 0.2 2165
DHA methyl ester 39.48 342 1.4 ± 0.1 2260
EPA methyl ester 39.80 316 1.6 ± 0.4 2274
Rt: Retention time; SD: Standard deviation; KI (exp): Kovats index (experimental).5. Discussion
A variety of organisms are capable of synthesizing substances that
have antibacterial and antifungal activities. These properties have
been observed in extracts obtained from a number of algae [9,10,11,
12,13]. Nevertheless, previous studies evaluating this characteristic in
C. rubrum are scarce. The results from the present study indicate that
the antimicrobial ability of C. rubrum is primarily driven by the lipophilic
extract. This is in agreement with the results reported by Hellio et al.
[19], Bansemir et al. [11] and Dubber and Harder [21], who observed
that lipophilic extracts (obtained using dichloromethane and hexane)
inhibited the growth of a variety of marine bacteria. Whereas Bansemir
et al. [11] did not ﬁnd inhibitory effects against Y. ruckeri, Dubber and
Harder [21] reported a growth inhibition between 50 and 90% on the
same bacteria. The hexane extract of C. rubrum exhibited antibacterial
activity at 10,600 μgml-1. In our research, theDCMof C. rubrumpresented
100% bacterial inhibition on Y. ruckeri at approximately 500 μg ml-1.
There are no reports regarding the antifungal activity of C. rubrum.
The present study is the ﬁrst study that has reported the antifungal
activity of this alga against S. parasitica. The maximum activity
for DCM and for stearic acid (N17.6% of inhibition) occurred at
250 μgml-1. These results are consistentwith other studies of antifungal
inhibition in Rhodophyta seaweeds. Indeed, the ethyl acetate and
chloroform extracts of Solieria robusta inhibited the growth of several
fruit spoiling fungi [36]. The results reported by Stein et al. [17] indicated
that hexane and chloroform extracts obtained from several Laurencia
species possess antifungal properties.
The present results agree with those reported in other Rhodophyta
algae studies. Bansemir et al. [37] observed that the dichloromethane
extract of Laurencia chondrioides (2mgdisk-1)was active on Pseudomonas
anguilliseptica (Gram-negative) with an inhibition of 15.0 ± 7.3 mm, but
it was not active on Y. ruckeri. In another study, the dichloromethane
extracts (2 mg disk-1) obtained from Asparagopsis armata, Falkenbergia
rufolanosa and Gracilaria corneawere active on Y. ruckeriwith inhibitions
of 21.3 ± 1.7, 13.3 ± 1.9 and 9.0 ± 2.6 mm, respectively, whereas
C. rubrum extracts were not active [11]. Karabay-Yavasoglu et al.
[38] found that an inhibition of 15 mm was obtained using a
chloroformextract from Jania rubens (4mgdisk-1) onEnterobacter cloacae
(Gram-negative). It is difﬁcult to assess the antimicrobial activity against
S. parasitica because there are no reports about the fungal inhibition
induced by algae extracts. Several studies have shown that medicinal
plants, chitosan, humic substances and compounds isolated from bacteria
have antifungal activity against S. parasitica. The active compound
Oridamycin A, which was isolated from Streptomyces sp., exhibited
an anti-S. parasitica activity with a MIC value of 0.3 μg ml-1 [26].
Table 3
Antimicrobial activity of the DCM compound mixtures against Y. ruckeri and S. parasitica.
Compound RS MC FA FAE IND
Hexadecane
Myristic acid • • •
Ethyl myristate • • •
Hexahydrofarnesyl acetone
Hexadecenoic acid, Z-11
Palmitic acid • • • •
Ethyl palmitate • • •
Phytol • • •
Oleic acid • • •
Ethyl linoleate
Ethyl linolenate
Stearic acid • • •
Methyl DHA
Methyl EPA
% of DCM 86 71 34 8 –
1Antibacterial activity (mm) 9.0 ± 0.5a⁎ 8.5 ± 0.2a 7.0 ± 0.1b 7.0 ± 0.1b b 8.0 ± 0.0
2Antifungal activity (%) 15.3 ± 0.1b 11.2 ± 0.2c 18.2 ± 0.5a 10.9 ± 0.2c b 17.9 ± 0.1
1 Concentration tested:1 mg disk-1; 2 250 μg ml-1perplate. RS: reconstitutedsample; FA: fattyacid; FAE: fattyacidesters;MC:maincompounds; IND:single compounds(commercial standards).
⁎ The means that are followed by the same letter do not differ signiﬁcantly at p b 0.05 (Conover–Inman test).
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plants produced a fungal inhibition growth between 11 and 100%
at 250 μg ml-1. Meinelt et al. [28] observed that humic substances
from non-eutrophicated freshwater ecosystems produced a 40%
inhibition of S. parasitica growth at 250 μg ml-1.
Dubber and Harder [21] hypothesized that the antibacterial effect of
C. rubrum extracts is due to the presence of signiﬁcant quantities of
unidentiﬁed fatty acids. Hence, this is the ﬁrst report about active
metabolites from the lipophilic extract of C. rubrum. In this study, 7 of
the 14 identiﬁed metabolites were tested on the pathogens. These
metabolites included fatty acids, fatty acid methyl esters and an acyclic
diterpene alcohol. Stearic acid was the most active compound against
S. parasitica, but none of the identiﬁed compounds were more active
than the dichloromethane fraction against Y. ruckeri. According to
Bansemir et al. [37], the antimicrobial activity of the extract could be a
synergistic effect of its constituents because the pure compounds only
showed aweakeffect (the exceptionwas the stearic acid activity against
S. parasitica).
Many antibacterial metabolites have been isolated from aqueous
or very polar extracts of red algae [40,41,42]. Despite numerous
studies that show the biological activity of polar compounds, it is not
uncommon to ﬁnd antimicrobial activity based on lipophilic extracts
obtained from algae. It seems that the use of lipophilic compounds in
defense is an effective adaptation that ensures the presence of the
active compound in the aquatic system as long as possible. In
addition, water-insoluble compounds are also advantageous in
that they diffuse slowly into the seawater, which ensures that the
potency of the metabolite will remain intact for some period [43].
Several antimicrobial metabolites, including diterpenes, bromophenols,
sesquiterpenoids and halogenated metabolites, share two aspects:
their small molecular size and their lipophilic character. These
physicochemical attributes are suggested to be of critical signiﬁcance
for metabolites to function in natural defense [44].
Other than the stearic acid activity against S. parasitica, none of
the DCM compound mixtures were more active than the DCM.
The ﬁndings that none of the DCM compounds were responsible
for the antibacterial activity and that the reconstituted sample
(86% of the DCM) was less active than the DCM indicate that a
synergistic effect may be occurring. Although there are no reports
of synergism among algae metabolites, this phenomenon is
observed in plants. Sökmen et al. [45] observed synergism between
the antimicrobial compounds obtained from the essential oil of
Achillea biebersteinii. The essential oil was fractioned by column
chromatography, and 9 extracts were obtained and tested. Theauthors observed that the activity was mainly observed in the
extracts that contained eucalyptol and camphor, followed by
those containing borneol and piperitone. In addition, Carpinella
et al. [46] observed an antifungal synergistic effect between
scopoletin, vanillin, 4-hydroxyl-3-methoxycinnamaldehyde and
pinoresinol that were isolated fromMelia azedarach fruits. Although
the major components of a natural sample generally represent its
biological features, they are not necessarily responsible for the
greatest activities [47]. Various minor components may contribute to
the biological activities [48]. Chairgulprasert et al. [49] indicated that
minor components of volatile oils may produce an antimicrobial effect
when combinedwith otherminor active components. Thus, it is possible
that 2-decen-1-ol, aminor component of the essential oil of Elettariopsis
curtisii, may enhance the essential oil's antimicrobial activity. In the
DCM of C. rubrum, minority compounds (14% of DCM) or their mixtures
could be responsible for activity.
The present results could indicate the occurrence of synergy
between the DCM components because i) weak antibacterial activity
was observed when the DCM compounds were evaluated separately,
ii) the reconstituted sample (86%) had weak antibacterial activity, and
iii) there was a trend toward increased antibacterial activity as more
of the DCM compounds were included in the tested sample.
The possible mechanisms of the antimicrobial activity of fatty
acids can explain the synergy between the DCM components. The
antibacterial activity of fatty acids depends on their structure. Although
there is disagreement in the literature, some general considerations
are possible. The free carboxylic group is the most important structural
requisite for antibacterial activity because it allows an optimal insertion
into cells that have hydrogen-bond-acceptor groups in the membrane.
The corresponding esters have little or no activity [50]. Other structural
factors that modulate the antimicrobial activity of fatty acids are
the length and degree of unsaturation of the carbon chain and the
stereochemistry of the unsaturation.
Due to the amphipathic character of fatty acids, themicroorganism's
membrane is the target of fatty acids. After fatty acid-induced damage
occurs, other molecules can penetrate the membrane and affect
different metabolic processes [51].
C. rubrum is an interesting candidate to investigate for active
metabolites against Y. ruckeri and S. parasitica. In summary, the
growth of the Y. ruckeri and S. parasitica pathogens was inhibited to
varying degrees by extracts from C. rubrum. Because of the natural origin
of the extracts or pure compounds from C. rubrum, they have a lower
hazard potential than drugs and are a potential alternative to prevent
and control outbreaks of salmonid diseases.
130 Y. Cortés et al. / Electronic Journal of Biotechnology 17 (2014) 126–131Concluding remarks
The present study determined that C. rubrum contains metabolites
that possess antibacterial and antifungal activities againstﬁsh pathogens.
The lipophilic extract was shown to be active against Y. ruckeri and
S. parasitica; thus, the results suggest the use of C. rubrum as a source of
antimicrobial compounds.
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